Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Few pharmas to profit off CV growth
Few pharmas to profit off CV growth
Few pharmas to profit off CV growth
Submitted by
admin
on March 8, 2010 - 9:10am
Source:
Fierce Pharma
News Tags:
Pfizer
Lipitor
Plavix
Sanofi
Bristol-Myers Squibb
Crestor
AstraZeneca
Headline:
Few pharmas to profit off CV growth
Do Not Allow Advertisers to Use My Personal information
